Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATF4 | P18848 | 1/20 | 0.44 |
| ▸ | SCN9A | Q15858 | 19/20 | 0.43 |
| ▸ | SCN10A | Q9Y5Y9 | 3/20 | 0.43 |
| ▸ | SCN7A | Q01118 | 3/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.43 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21390107 | 0.91 | ATF4 (0.50) | ATF4SCN9ASCN10ASCN7AKCNH2 | |
| SCHEMBL21390171 | 0.91 | ATF4 (0.50) | ATF4SCN9ASCN10ASCN7AKCNH2 | |
| SCHEMBL21390170 | 0.91 | ATF4 (0.50) | ATF4SCN9ASCN10ASCN7AKCNH2 | |
| SCHEMBL23332911 | 0.81 | SCN9A (0.43) | SCN9ASCN10ASCN7AKCNH2SCN5A | |
| SCHEMBL23333276 | 0.81 | SCN9A (0.42) | SCN9ASCN10ASCN7AKCNH2SCN5A | |
| SCHEMBL23332909 | 0.79 | ATF4 (0.38) | ATF4SCN9ASCN10ASCN7AKCNH2 | |
| SCHEMBL21390322 | 0.78 | ATF4 (0.48) | ATF4SCN9ASCN10ASCN7AKCNH2 | |
| SCHEMBL21390140 | 0.76 | ATF4 (0.47) | ATF4SCN9ASCN10ASCN7AKCNH2 | |
| SCHEMBL25963889 | 0.74 | ATF4 (0.45) | ATF4SCN9ASCN10ASCN7AKCNH2 | |
| SCHEMBL25963238 | 0.73 | ATF4 (0.53) | ATF4SCN9ASCN10ASCN7AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019183589-A1 | MODULATORS OF EUKARYOTIC INITIATION FACTOR 2 | DENALI THERAPEUTICS INC. (US) | 2019-09-26 | — | — | WO | disclosed |